Feasibility of Eribulin Mesylate in older patients with locally advanced or metastatic breast cancer: A post-hoc analysis of the ESEMPiO study

S. Barni; L. Livraghi; A. Gravina; F. Martella; L. D'Onofrio; M. Morritti; A. Michelotti; P. Vici; L. Mentuccia; L. Porcu; M. Orditura; F. Puglisi; ESEMPiO Group

doi:10.1016/j.jgo.2019.05.003

Feasibility of Eribulin Mesylate in older patients with locally advanced or metastatic breast cancer: A post-hoc analysis of the ESEMPiO study

S. Barni, L. Livraghi, A. Gravina, F. Martella, L. D'Onofrio, M. Morritti, A. Michelotti, P. Vici, L. Mentuccia, L. Porcu, M. Orditura, F. Puglisi, ESEMPiO Group

Istituto Regina Elena

Research output: Contribution to journal › Article › peer-review

Original language	Italian
Pages (from-to)	990-993
Number of pages	4
Journal	Journal of Geriatric Oncology
Volume	10
Issue number	6
DOIs	https://doi.org/10.1016/j.jgo.2019.05.003
Publication status	Published - 2019

Access to Document

10.1016/j.jgo.2019.05.003

Cite this

Barni, S., Livraghi, L., Gravina, A., Martella, F., D'Onofrio, L., Morritti, M., Michelotti, A., Vici, P., Mentuccia, L., Porcu, L., Orditura, M., Puglisi, F., & Group, ESEMP. (2019). Feasibility of Eribulin Mesylate in older patients with locally advanced or metastatic breast cancer: A post-hoc analysis of the ESEMPiO study. Journal of Geriatric Oncology, 10(6), 990-993. https://doi.org/10.1016/j.jgo.2019.05.003

Barni, S, Livraghi, L, Gravina, A, Martella, F, D'Onofrio, L, Morritti, M, Michelotti, A, Vici, P, Mentuccia, L, Porcu, L, Orditura, M, Puglisi, F & Group, ESEMP 2019, 'Feasibility of Eribulin Mesylate in older patients with locally advanced or metastatic breast cancer: A post-hoc analysis of the ESEMPiO study', Journal of Geriatric Oncology, vol. 10, no. 6, pp. 990-993. https://doi.org/10.1016/j.jgo.2019.05.003

@article{29495e06d31747258c25bbc9069abadd,

title = "Feasibility of Eribulin Mesylate in older patients with locally advanced or metastatic breast cancer: A post-hoc analysis of the ESEMPiO study",

keywords = "Aged, Eribulin, Metastatic breast cancer, Safety",

author = "S. Barni and L. Livraghi and A. Gravina and F. Martella and L. D'Onofrio and M. Morritti and A. Michelotti and P. Vici and L. Mentuccia and L. Porcu and M. Orditura and F. Puglisi and ESEMPiO Group",

note = "LR: 20190517; JID: 101534770; OTO: NOTNLM; 2019/02/21 00:00 [received]; 2019/03/29 00:00 [revised]; 2019/05/03 00:00 [accepted]; 2019/05/18 06:00 [entrez]; 2019/05/18 06:00 [pubmed]; 2019/05/18 06:00 [medline]; aheadofprint M1 - Journal Article",

year = "2019",

doi = "10.1016/j.jgo.2019.05.003",

language = "Italian",

volume = "10",

pages = "990--993",

journal = "Journal of Geriatric Oncology",

issn = "1879-4068",

publisher = "Elsevier Limited",

number = "6",

}

TY - JOUR

T1 - Feasibility of Eribulin Mesylate in older patients with locally advanced or metastatic breast cancer: A post-hoc analysis of the ESEMPiO study

AU - Barni, S.

AU - Livraghi, L.

AU - Gravina, A.

AU - Martella, F.

AU - D'Onofrio, L.

AU - Morritti, M.

AU - Michelotti, A.

AU - Vici, P.

AU - Mentuccia, L.

AU - Porcu, L.

AU - Orditura, M.

AU - Puglisi, F.

AU - Group, ESEMPiO

N1 - LR: 20190517; JID: 101534770; OTO: NOTNLM; 2019/02/21 00:00 [received]; 2019/03/29 00:00 [revised]; 2019/05/03 00:00 [accepted]; 2019/05/18 06:00 [entrez]; 2019/05/18 06:00 [pubmed]; 2019/05/18 06:00 [medline]; aheadofprint M1 - Journal Article

PY - 2019

Y1 - 2019

KW - Aged

KW - Eribulin

KW - Metastatic breast cancer

KW - Safety

U2 - 10.1016/j.jgo.2019.05.003

DO - 10.1016/j.jgo.2019.05.003

M3 - Articolo

VL - 10

SP - 990

EP - 993

JO - Journal of Geriatric Oncology

JF - Journal of Geriatric Oncology

SN - 1879-4068

IS - 6

ER -